Skip to main content

Christina Eleanor Barkauskas

Associate Professor of Medicine
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Box 2629 Med Ctr, Durham, NC 27710
Dept of Medicine, Durham, NC 27710

Overview


I am a physician-scientist and stem cell biologist focused on understanding the fundamental mechanisms involved in lung injury and repair. I am particularly interested in determining the critical components of the alveolar epithelial stem cell niche and the cellular crosstalk signals that dictate cell identity and behavior during steady state maintenance and repair after injury and infection. I believe this work is fundamental to better understanding the biology of the human lung and the pathogenesis of idiopathic pulmonary fibrosis (IPF), a disease that is characterized by relentless scar accumulation in the lung with only minimally effective therapy short of lung transplant.

Through my work, I have developed several areas of expertise which include the following: 1) Development and use of mouse models to genetically manipulate and lineage trace specific cell populations; 2) Isolation and characterization of murine lung cell subpopulations by flow cytometry; 3) Development and use of an ex vivo 3-dimensional organoid assay to study the self-renewal and differentiation of murine alveolar epithelial stem cells and their niche components; 4) Isolation and 3-dimensional culture of alveolar epithelial cells from fresh human lung; 5) Development and analysis of models of experimental lung fibrosis.

Current Duke Appointments & Affiliations


Associate Professor of Medicine · 2023 - Present Medicine, Pulmonary, Allergy, and Critical Care Medicine, Medicine
Affiliate of the Duke Regeneration Center · 2021 - Present Duke Regeneration Center, Basic Science Departments

Recent News Items


Published September 23, 2022
Latest Research on Long COVID with Dr. Mary Klotman and Dr. Christina Barkauskas

View All News Items

Recent Scholarly Works


Prognostic Value of Lung Injury Biomarkers in Patients Hospitalized With COVID-19 Without Respiratory Failure at Admission.

Journal article Crit Care Med · August 1, 2026 OBJECTIVES: The COVID-19 pandemic highlighted an urgent need to more efficiently identify patients at highest risk for developing respiratory failure. We investigated whether plasma levels of lung injury biomarkers are associated with progression to respir ... Full text Link to item Cite

Hyaluronan Ameliorates Viral Pneumonia in Mice and Humans by Inhibiting Transcription Factor E2F1.

Journal article Am J Respir Cell Mol Biol · January 1, 2026 Viral lung infections are a major cause of morbidity and mortality worldwide. Despite significant advances in vaccines and antivirals, there remains a tremendous need for broadly applicable treatments that can be utilized across viral infections. Before in ... Full text Link to item Cite

Hyaluronan Directs Alveolar Type II Cell Response to Acute Ozone Exposure in Mice.

Journal article Am J Respir Cell Mol Biol · July 2025 Becoming more frequent because of climate change, ozone (O3) exposures can cause lung injury. Alveolar type 2 (AT2) cells and hyaluronan (HA), a matrix component, are critical to repairing lung injury and restoring homeostasis. Here, we define the impact o ... Full text Link to item Cite
View All Scholarly Works

Recent Grants


1/2 PREcision VENTilation to attenuate Ventilation-Induced Lung Injury (PREVENT VILI)

Clinical TrialPrincipal Investigator · Awarded by Beth Israel Deaconess Medical Center · 2024 - 2031

ARDS, Pneumonia, and Sepsis Phenotyping Consortium Clinical Centers (APS)_Fixed Budget

ResearchPrincipal Investigator · Awarded by Intermountain Healthcare · 2024 - 2029

View All Grants

Education


Duke University, School of Medicine · 2004 M.D.